County government employees could see a 12.2% increase in health care premiums next year under preliminary information ...

So far, benefits associated with consistent GLP-1 use in curbing medical spending lack sufficient data-backed evidence. It’s ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees. The bill would eliminate pharmacy benefit managers’ (PBM) usage when it ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Wegovy, which has been used for weight loss reasons, is not going to be covered by a Medicare Advantage plan or for Part D if it's prescribed for weight loss reasons.

Due to current legislation, Medicare Part D or C plans may only cover Zepbound for obstructive sleep apnea. However, the Centers for Medicare & Medicaid Services may expand weight loss medication ...

The injectable drugs have exploded in popularity due to the potentially life-changing weight loss that some patients experience.

The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity treatments.